| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GTF2IRD2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | SRRM4 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | SSTR2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | HDAC1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | TIGD1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | GCLM | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | ZNF154 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | NXPE2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | FBXW4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | GRM3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
